RadioNano Therapeutics Inc.
PrivateLast Round
Series A
Dec 23, 2024
Total Funding Raised
$3.91M
Company Overview
RadioNano Therapeutics Inc. is a biotechnology company that develops nanoparticle-based drugs for Boron Neutron Capture Therapy (BNCT) to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RadioNano Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
RadioNano Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 23, 2024 | ||||
| Seed | Apr 1, 2024 |
RadioNano Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series A |
| Kyoto Capital Partners | Series A |
| Mitsubishi UFJ Capital | Series A |
| Kyoto University Innovation Capital | Series A, Seed |
| Japan Science and Technology Agency | Series A |
| Zhongxin Capital Holdings | Series A |
| SMBC Venture Capital | Series A |
RadioNano Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RadioNano Therapeutics Inc.'s valuation, stock price, and market status.